Caricamento...
Ocular Abnormalities in Patients Treated with a Novel Anti-GD2 Monoclonal Antibody, hu14.18K322A
PURPOSE: To determine the incidence and factors associated with the development of mydriasis and impaired accommodation in patients with refractory or recurrent neuroblastoma receiving the anti-GD2 antibody, hu14.18K322A. PROCEDURE: Eligible patients with refractory or recurrent neuroblastoma receiv...
Salvato in:
| Pubblicato in: | J AAPOS |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4698825/ https://ncbi.nlm.nih.gov/pubmed/25818285 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaapos.2014.11.005 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|